Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119925) titled 'An open-label, multicenter phase I/IIa clinical study evaluating the safety, tolerability, pharmacokinetics, and preliminary efficacy of ZL-85FA tablets in treating advanced solid tumors' on March 5.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: The First Affiliated Hospital Of Anhui Medical University

Condition: Advanced Solid Tumor

Recruitment Status: Not Recruiting

Phase: 1-2

Date of First Enrollment: 2026-03-06

Target Sample Size: Experimental group:72;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=297643

Publishe...